Callum Titchmarch
Analyst
Morgan Stanley
Equibles does not estimate personal net worth.
About Callum Titchmarch
Callum Titchmarch is recorded as Analyst at Morgan Stanley. Callum Titchmarch has spoken on 2 earnings calls across 2 companies, most recently for Adaptive Biotechnologies Corp on July 29, 2026. Those appearances were for Adaptive Biotechnologies Corp (ADPT) and iRhythm Holdings, Inc. (IRTC). The companies whose calls Callum Titchmarch spoke on are classified in the Healthcare sector.
Callum Titchmarch on recent calls
“Maybe following up on Dan's question on the separation, I guess folks are trying to work out what the next step looks like and how the MRD business could look on its own.”
“Just on the 483 observations, and I think previously you've messaged to us that internally you feel like you can remediate everything there that you've committed to by kind of mid-2025.”
Affiliation history
-
Morgan Stanley
Analyst
Transcript header (unverified)
Current